Guide · Reviewed July 26, 2026
The Ozempic pill: what replaced Rybelsus
Same molecule, new name, lower milligram numbers — and one distinction most coverage of this change gets wrong.
The short answer
The Ozempic pill is oral semaglutide for type 2 diabetes. Novo Nordisk retired the Rybelsus brand in the US and began dispensing the tablets under the Ozempic name on May 4, 2026. The tablet was reformulated to absorb better, so the strengths changed: 1.5 mg, 4 mg and 9 mg replace Rybelsus 3 mg, 7 mg and 14 mg. Self-pay runs $149/mo (1.5 mg) to $299/mo (9 mg) depending on dose.
Key takeaways
- The "Ozempic pill" is oral semaglutide in tablet form. It replaced the Rybelsus brand in the US, with pharmacies beginning to dispense it on May 4, 2026.
- Doses map one for one: Ozempic tablets 1.5 mg, 4 mg and 9 mg correspond to Rybelsus 3 mg, 7 mg and 14 mg. The new tablet is reformulated to absorb better, so a smaller number of milligrams does the same job.
- It is approved for type 2 diabetes, not weight loss. The oral semaglutide approved for chronic weight management is Wegovy pill, a 25 mg tablet — a different brand with a different price.
- Self-pay through the manufacturer: $149/mo (1.5 mg), $199/mo (4 mg), $299/mo (9 mg), where one month means one bottle of 30 tablets.
- With commercial insurance that covers it, as little as $25/mo — but the card pays at most 100 dollars a month, so a large copay is only partly covered.
- You cannot switch automatically. Your prescriber has to write a new prescription, and the label says not to switch between the two tablet products during the first 30 days of treatment.
- Rybelsus has not been withdrawn worldwide — Novo continues to market it outside the US. This change is American-only.
Rybelsus dose to Ozempic tablet dose
The milligram numbers dropped because the tablet changed, not because the dose got weaker. Novo reformulated it for better bioavailability, so less semaglutide delivers the same exposure — the company describes the strengths below as equivalent in efficacy and safety to the ones they replace.
| Was | Now | What that dose is for |
|---|---|---|
| Rybelsus 3 mg | Ozempic tablets 1.5 mg | Starting dose — the first 30 days, to let the stomach adjust. Not a maintenance dose. |
| Rybelsus 7 mg | Ozempic tablets 4 mg | First maintenance step, usually after at least 30 days on the starting dose. |
| Rybelsus 14 mg | Ozempic tablets 9 mg | Highest tablet strength currently marketed in the US. |
Read this as a mapping, not as permission to convert your own dose. The switch needs a new prescription, and the label specifically says not to move between the two tablet products during the first 30 days of treatment.
What it costs
Novo publishes self-pay prices by strength. One month means one bottle of 30 tablets — worth noting, because the company defines a month differently for its pens.
- $149/mo (1.5 mg) — the starting strength.
- $199/mo (4 mg) — the first maintenance step.
- $299/mo (9 mg) — the highest marketed strength.
- as little as $25/mo with commercial insurance that covers Ozempic — but the card contributes at most $100 a month, for up to 48 months. If your copay is larger than that, you pay the difference.
Government insurance — Medicare, Medicaid, TRICARE, VA — cannot use the savings card at all; federal anti-kickback rules bar it. Full route-by-route breakdown on what the Ozempic pill costs.
Taking it: the 30-minute rule that decides whether it works
Semaglutide is a peptide, and peptides are normally digested before they can be absorbed — which is why almost every other drug in this class is injected. The tablet solves that with an absorption enhancer that only works on a genuinely empty stomach. So: one tablet after waking, swallowed whole with no more than a sip of plain water, then at least 30 minutes before food, other drinks, or any other oral medication. Do not split, crush or chew it. Shortening that window is the most common reason the tablet disappoints, and it looks identical to the drug not working.
Is Rybelsus gone?
In the US, the brand is being retired. FDA's drug shortage database lists semaglutide tablets under the Rybelsus NDCs as to be discontinued, posted June 4, 2026, noting the products are replaced by Ozempic tablets. No recall was issued and nothing was found unsafe — this is a branding and formulation change. Novo continues to sell Rybelsus under that name outside the United States, so international sources describing it as a current product are not wrong, just not about the US market.
Telehealth providers that prescribe semaglutide
SponsoredIf you need a prescriber to have the switching conversation with, these partners handle semaglutide. We earn a commission if you sign up — it does not change your price.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
Common questions about this medication
What is the Ozempic pill?
It is semaglutide in tablet form, taken once a day, approved for adults with type 2 diabetes to improve blood sugar and to reduce the risk of major cardiovascular events in people who are also at high risk of them. It contains the same molecule as the Ozempic injection pen. Novo Nordisk introduced it in US pharmacies on May 4, 2026, replacing the Rybelsus brand name.
Is the Ozempic pill the same as Rybelsus?
Same molecule, same daily tablet, but not the same product. Novo reformulated the tablet to improve how much semaglutide the body absorbs, which is why the new strengths are lower numbers: Ozempic tablets 1.5 mg, 4 mg and 9 mg correspond to Rybelsus 3 mg, 7 mg and 14 mg. Novo states the efficacy and safety profile is the same as the original formulation. The Rybelsus name is being retired in the US only — it continues to be sold under that name in other countries.
Does the Ozempic pill work for weight loss?
It is not approved for weight loss. Ozempic tablets are labeled for type 2 diabetes. The oral semaglutide the FDA approved for chronic weight management is a separate product — Wegovy pill, a 25 mg tablet approved in December 2025 on the OASIS 4 trial. If weight management is the goal, that is the product to ask a prescriber about, not this one. People with type 2 diabetes often do lose weight on semaglutide, but that is an effect of the medicine rather than the indication it was approved for.
How much does the Ozempic pill cost?
Paying the manufacturer directly, without insurance: $149/mo (1.5 mg), $199/mo (4 mg) and $299/mo (9 mg), where Novo defines one month as a single bottle of 30 tablets. If you have commercial insurance that covers Ozempic, the savings offer brings it to as little as $25/mo, capped at 100 dollars of help per month and running up to 48 months. Government plans — Medicare, Medicaid, TRICARE, VA — are excluded from the card by law.
How do I switch from Rybelsus to the Ozempic pill?
Through your prescriber — the switch is not automatic and the pharmacy cannot substitute one for the other, because they are different products with different strengths. Two rules come straight from the prescribing information: do not switch between the two tablet products during the initiation phase, meaning days 1 to 30 of treatment; and when you do switch, start the new product the day after you stop the old one rather than overlapping them. Novo has told current Rybelsus patients to keep taking their medication as directed until they have had that conversation.
Can I switch from the Ozempic injection to the tablets?
The label addresses this specific case: someone taking the 0.5 mg Ozempic injection may move to tablets, starting 4 mg or 9 mg one week after the last injection. Higher injection doses are not covered by that instruction, so anyone on 1 mg or 2 mg needs their prescriber to make the call rather than reading across from the 0.5 mg rule.
How do you take the Ozempic pill?
Once daily, swallowed whole with no more than a sip of plain water, on an empty stomach after waking. Do not split, crush or chew it. Then wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines — semaglutide in tablet form is poorly absorbed if food or other drugs are in the stomach, which is the whole engineering problem an oral peptide has to solve. Skipping that wait is the most common reason the tablet underperforms.
Is Rybelsus discontinued?
In the United States, yes, as a brand. FDA's drug shortage database records semaglutide tablets under the Rybelsus NDCs as "to be discontinued", posted June 4, 2026, with the note that the products are replaced by Ozempic tablets. This is a branding and formulation change rather than a safety withdrawal: no recall was issued, and the molecule continues to be sold both as tablets under the Ozempic name and as the Ozempic injection. Outside the US, Rybelsus remains on the market under its own name.
Related
Sources: Novo Nordisk press release, May 1, 2026; the combined RYBELSUS and OZEMPIC tablets prescribing information on DailyMed, revised January 2026; FDA's drug shortage database via openFDA; and Novo's published Ozempic price guide, all read on July 26, 2026. Educational only — this is not medical advice, and dose changes belong with your prescriber.